CCDI Webinar Series (Registration) | Events Registration
Registration
Related Articles
OA Virtual conferences
Sorry, your request to load the app is timing out. Please check your internet connection and refresh the page. If the issue continues, try in…
Genetic Test Predicts Survival Benefit From Docetaxel in… : Oncology Times
An abstract is unavailable.
As Trump’s second term nears, Republican support for NIH is at a low point By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research – The Cancer Letter
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier…
OA Virtual conferences
Sorry, your request to load the app is timing out. Please check your internet connection and refresh the page. If the issue continues, try in…
Patient navigation benefits health systems, improves care Initial data presented at the White House come a year after CMS payment began – The Cancer Letter
One year after the Centers for Medicare & Medicaid Services made the decision to pay for patient navigation services, data from early adopters show that…
Society for Neuro-Oncology Annual Meeting
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The Skin Cancer Foundation (@skincancerorg.bsky.social)
We save and improve lives by empowering people to take a proactive approach to daily sun protection and the early detection and treatment of skin…
Cedars-Sinai spearheads first national certification program for COE staff at cancer centers – The Cancer Letter
The NCI Cancer Center Support Grant requires community outreach and engagement, but the design and implementation of COE programs, as well as staff training, are…
Menin inhibitors emerge as new treatment for advanced AML – The Cancer Letter
The world of cancer treatments continues to evolve, and for those diagnosed with blood cancers, a new option can be found in menin inhibitors—the latest…
Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer
David S. Miller, MD, discusses key efficacy, safety, and quality-adjusted survival data with selinexor in TP53 wild-type endometrial cancer.